Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial
Alimentary Pharmacology & Therapeutics · 2025-04 · 61 (8) · 1276-1289
DOI: 10.1111/apt.70041 ↗At a glance
Randomisierte kontrollierte Studie in Alimentary Pharmacology & Therapeutics, published online on 2025-02-18. Written by Jessica A Fitzpatrick and 7 co-authors. Institution: Department of Gastroenterology, School of Translational Medicine, Monash University and Alfred Health, Melbourne, Victoria, Australia. Major MEDLINE topics: Crohn Disease, Emulsifying Agents. Cited 24 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: Eva and Tom Breuer Foundation, National Health and Medical Research Council, Crohn's and Colitis Foundation.
Abstract (original language)
Background
Advice to avoid dietary emulsifiers in Crohn's disease (CD) is based on preclinical data.
Aims
To examine the effect of diets high (HED) and low (LED) in emulsifiers in the food supply on disease activity in CD.
Methods
In a double‐blinded, randomised feeding study, we randomised adults with symptomatic, sonographically active CD with ileal involvement on ≥ 2 months' stable medical therapy to 4 weeks of a HED or LED modelled on Australian healthy eating guidelines. We measured the Harvey‐Bradshaw Index (HBI), sonographic indices (IBUS‐SAS, bowel wall thickness), quality of life (QOL) and fatigue at baseline and study completion.
Results
We randomised 24 patients, mean age 37 (95% CI 32, 41) years, 12 male, HBI 6 (6, 8), bowel wall thickness 6.0 (5.5–6.6) mm. Adherence was > 95%. Clinical remission (HBI < 5) occurred in 9/12 on HED and 7/12 on LED; 2 and 3, respectively, withdrew early with increasing gastrointestinal symptoms. IBUS‐SAS fell from 51 (35, 68) to 33 (15, 51) on HED ( p = 0.014) and from 57 (38, 76) to 44 (29, 59) on LED ( p = 0.01). Bowel wall thickness reduced by 34% on HED and 15% on LED in those who completed the study. QOL and fatigue improved on both diets ( p ≤ 0.05). There were no statistically significant differences in outcomes between diets.
Conclusions
In the context of a healthy diet, the emulsifier content had no influence over disease activity over 4 weeks in patients with CD. Recommendations to avoid emulsifiers in patients with active CD are not supported. Australian New Zealand Clinical Trials Registry (ACTRN12619001099112).
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology, School of Translational Medicine, Monash University and Alfred Health, Melbourne, Victoria, Australia.
ORCID profiles: Jessica A Fitzpatrick, Peter R Gibson, Kirstin M Taylor, Ellen J Anderson, Antony B Friedman, Zaid S Ardalan, Rebecca L Smith, Emma P Halmos
Funding
- Eva and Tom Breuer Foundation
- National Health and Medical Research Council
- Crohn's and Colitis Foundation
- Crohn's and Colitis Australia
Cite
APA
Fitzpatrick, J. A., Gibson, P. R., Taylor, K. M., Anderson, E. J., Friedman, A. B., Ardalan, Z. S., Smith, R. L., & Halmos, E. P. (2025). Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial. Alimentary Pharmacology & Therapeutics, 61(8), 1276-1289. https://doi.org/10.1111/apt.70041
Vancouver
Fitzpatrick JA, Gibson PR, Taylor KM, Anderson EJ, Friedman AB, Ardalan ZS, et al. Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial. Alimentary Pharmacology & Therapeutics. 2025;61(8):1276-1289. doi:10.1111/apt.70041
BibTeX
@article{Fitzpatrick2025,
author = {Fitzpatrick, Jessica A and Gibson, Peter R and Taylor, Kirstin M and Anderson, Ellen J and Friedman, Antony B and Ardalan, Zaid S and Smith, Rebecca L and Halmos, Emma P},
title = {Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
volume = {61},
number = {8},
pages = {1276--1289},
doi = {10.1111/apt.70041}
}
EUVIMED